United Kingdom Travel Vaccine Market Insights Forecasts to 2033

• The United Kingdom Travel Vaccine Market Size was valued at USD 324.5 Million in 2023.
• The Market Size is Growing at a CAGR of 9.8% from 2023 to 2033
• The U.K. Travel Vaccine Market Size is Expected to reach USD 826.5 Million by 2033

The United Kingdom Travel Vaccine Market is anticipated to exceed USD 826.5 Million by 2033, growing at a CAGR of 9.8% from 2023 to 2033. The growing travel & tourism and increasing incidences of infectious diseases are driving the growth of the travel vaccine market in the United Kingdom.     

Market Overview

Travel vaccine, often known as travel immunizations, are the shots that travellers receive before travelling to specific regions to help prevent them from acquiring deadly infections. It is advised to have these vaccinations to protect against illnesses that are common in either the destination or the country of origin. It is intended to safeguard travellers and stop the spread of illness within or between countries. Immunization is required for travel outside of the nation as a safety and precautionary measure to prevent the spread of infections. Countries have laws to protect their people from travel-associated illnesses. The National Health Service (NHS) of the UK organizes routine vaccination schedules for its residents. A person needs to get vaccinated against infectious diseases like typhoid, yellow fever, and hepatitis A when traveling outside the UK. The expansion of vaccine availability, development of customized vaccination plans and ongoing vaccine research and development are leveraging the market opportunity of travel vaccine. Furthermore, the market is anticipated to increase at a rapid pace due to the adoption of digital health solutions for pre-travel consultations.

Report Coverage

This research report categorizes the market for the UK travel vaccine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the travel vaccine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the travel vaccine market.

Driving Factors

The UK is among the most popular international tourism destinations. According to Statista reports, the number of foreign tourists arriving in Europe increased by ~20% in 2021 compared to 2020. Thus, the increased travel & tourism are driving the UK travel vaccine market. Further, the rising prevalence of infectious diseases with the rising number of travel-associated infections diagnosed in the UK are driving the market growth.

Restraining Factors

For those who intend to travel, including volunteers and students, the high expense of vaccinations could be a barrier that is likely to restrain the UK travel vaccine market.

Market Segmentation

The United Kingdom Travel Vaccine Market share is classified into product and application.

• The meningococcal vaccines segment is anticipated to witness the fastest CAGR through the forecast period.

The United Kingdom travel vaccine market is segmented by product into hepatitis A, hepatitis B, meningococcal vaccines, and others. Among these, the meningococcal vaccines segment is anticipated to witness the fastest CAGR through the forecast period. The quadrivalent meningococcal vaccine known as MenACWY is a single injection that is given to children 2-3 weeks before the travel date. The rising emphasis on vaccination programs for children and initiatives by various organizations are propelling the market.

• The outbound travel segment dominates the market with the largest market share during the forecast period.

The United Kingdom travel vaccine market is segmented by application into domestic travel and outbound travel. Among these, the outbound travel segment dominates the market with the largest market share during the forecast period. Outbound travel is traveling outside of one’s own nations for business, leisure or other purposes. Business travel is s common reason for foreign travel. Spending on trips abroad by residents of the UK increased by 12% in 2021 over the previous year. Thus, there is an expected upsurge in market growth owing to the steady increase of tourist arrivals in the future.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the UK travel vaccine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GlaxoSmithKline plc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Merck & Co., Inc.
• Valneva SE
• Abbott
• Emergent BioSolutions Inc.
• SEQIRUS
• Dynavax technologies
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In December 2021, Emergent BioSolutions Inc. announced the first participant dosed in its phase 1 study, EBS-UFV-001, evaluating the safety, tolerability, and immunogenicity of the company’s investigational universal influenza vaccine candidate. This current version of Emergent’s universal influenza vaccine candidate contains multiple components intended to induce broad and supra-seasonal immunity against influenza A viruses.

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United Kingdom Travel Vaccine Market based on the below-mentioned segments:

United Kingdom Travel Vaccine Market, By Product

• Hepatitis A
• Hepatitis B
• Meningococcal Vaccines
• Others

United Kingdom Travel Vaccine Market, By Application

• Domestic Travel
• Outbound Travel